US Stocks closed mostly lower yesterday in a bumpy trading session as investors await news on what the Federal Reserve is going to do with interest rates later today.
US factory orders rose a paltry .1% last month, another sign pointing to slower economic here in the US in the 1st quarter. Economist had forecast a .5% increase. Non-durable goods dropped by .5% last month.
The FDA has approved the first drug specifically developed to treat postpartum depression after childbirth. Shares of Sage Therapeutics the company that developed the drug shot higher on the news. The drug is likely to be priced at $35,000 per treatment.
Shares of FedEx dropped 6% yesterday after the company reported earnings that missed expectations. The company also lowered expectations for the rest of the year for the 2nd time in 3 months over serious concerns about the global economy slowing down.
Google is planning to ask all Android smartphone users in Europe whether the want to switch to competing search engines. One of two concession the search giant is offering to stave off complaints and fines from the European Union antitrust regulators.
With Northwest Quadrant Wealth Management, I'm Tyler Simones